Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ultrasound technique aims to improve skin cancer surgery outcomes

NCT ID NCT07361666

Knowledge-focused Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether using a high-frequency ultrasound before surgery for common skin cancers on the head and neck can help surgeons remove the entire tumor the first time. About 400 adults with basal or squamous cell skin cancer will be in the study. Some will get the standard skin exam before surgery, and others will also get the ultrasound. The goal is to see if the ultrasound leads to fewer cases where cancer cells are left behind and lowers the chance of the cancer coming back within 5 years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2025

An estimate. Start dates often move.

Expected to finish

Nov 2033

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study will include all eligible cutaneous basal cell carcinomas (BCC) and cutaneous squamous cell carcinomas (cSCC) of the head and neck surgically treated at the Department of Otolaryngology. Each eligible lesion will constitute an independent study case. In patients with multiple tumors, each lesion may be included separately if it meets all inclusion criteria. Participation requires informed, written consent from the patient after reviewing the Patient Information Sheet.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Cutaneous lesion located in the head and neck region with a preoperative diagnosis of basal cell carcinoma (BCC) or squamous cell carcinoma (SCC), established by dermoscopy or biopsy, and qualified for surgical excision with curative intent. * patient age of 18 years or older. * Ability of patient to provide voluntary, informed, written consent for participation in the study. * Confirmation that the patient has read and understood the Patient Information Sheet. Exclusion Criteria: * Excisional biopsies without radical intent. * Lack of histopathologic confirmation of BCC or SCC in the postoperative specimen (incorrect dermoscopic qualification). * Inability to perform radical surgical excision due to excessive tumor extent, poor general condition of the patient, or lack of patient consent for surgery. * Pregnancy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Basal cell carcinoma (BCC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

basal cell carcinoma Margins of Excision Recurrence skin basal cell carcinoma skin carcinoma skin neoplasm skin squamous cell carcinoma skin squamous cell carcinoma in situ squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Basal cell carcinoma (BCC) Basal cell carcinoma of skin Basal cell carcinoma of the head and neck Cutaneous squamous cell carcinoma (CSCC) Cutaneous squamous cell carcinoma in situ (csccis) Cutaneous squamous cell carcinoma of the head and neck Non-melanoma skin cancer (NMSC)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • National Medical Institute of the Ministry of the Interior and Administration in Warsaw

    Warsaw, Masovian Voivodeship, 02-507, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.